- Center on Health Equity and Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Tumor Treating Fields Can Halt Glioblastomas
An electrical device glued to the scalp can slow cancer growth and prolong survival in people with the deadliest type of brain tumor, researchers reported on Saturday in Miami, at a meeting of the Society for Neuro-Oncology.
An electrical device glued to the scalp can slow cancer growth and prolong survival in people with the deadliest type of brain tumor, researchers reported on Saturday.
The device is not a cure and, on average, adds only a few months of life when used along with the standard regimen of surgery, radiation and chemotherapy. Some doctors have questioned its usefulness. But scientists conducting a new study said the device was the first therapy in a decade to extend life in people with glioblastomas, brain tumors in which median survival is 15 months even with the best treatment.
The disease affects about 10,000 people a year in the United States and is what killed Senator Edward M. Kennedy in 2009. It is so aggressive and hard to treat that even seemingly small gains in survival are considered important.
Link to the complete report on The New York Times: http://nyti.ms/1xxuYCc
Link to Novocure's PR on trial results: http://bit.ly/14AxSu2
Oncology Onward: A Conversation With Penn Medicine's Dr Justin Bekelman
December 19th 2023Justin Bekelman, MD, director of the Penn Center for Cancer Care Innovation, sat with our hosts Emeline Aviki, MD, MBA, and Stephen Schleicher, MD, MBA, for our final episode of 2023 to discuss the importance of collaboration between academic medicine and community oncology and testing innovative cancer care delivery in these settings.
Listen
